Lataa...
Cancer Immunotherapy Using Checkpoint Blockade
The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses in patients with a variety of cancers. This can be achieved by antibodies blocking the cytotoxic T lymphocyte antigen-4 (CTL...
Tallennettuna:
| Julkaisussa: | Science |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7391259/ https://ncbi.nlm.nih.gov/pubmed/29567705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aar4060 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|